Bath & Body Works Surges on Stock Recommendation; Klarna Drops on Guidance
Stock markets saw mixed movements with Bath & Body Works surging on a Citi upgrade to buy rating, while Klarna dropped on disappointing guidance despite beating profit expectations. Amylyx Pharmaceuticals also rallied significantly after its experimental drug met primary endpoints in late-stage trials. These moves reflect varied investor sentiment across retail, fintech, and pharmaceutical sectors.
1 Article
Trace's outlet lean is shown first — tap Left / Center / Right on each source to add your rating too.
- BloombergTrace: Center
Bath & Body Works Surges on Stock Recommendation; Klarna Drops on Guidance | Stock Movers
Stock markets saw mixed movements with Bath & Body Works surging on a Citi upgrade to buy rating, while Klarna dropped on disappointing guidance despite beating profit expectations. Amylyx Pharmaceuticals also rallied significantly after its experimental drug met primary endpoints in late-stage trials. These moves reflect varied investor sentiment across retail, fintech, and pharmaceutical sectors.
Rate outletRead original